Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Annette, Duck"'
Publikováno v:
Advances in Therapy
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible fibrotic lung disease that requires long-term treatment. Given the importance of adherence to treatment and management of adverse events (AEs), patients with IPF need lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe19b8e07407836a814f8d819bd48c37
http://europepmc.org/articles/PMC4349950
http://europepmc.org/articles/PMC4349950
Autor:
Klaus Geissler, Marlies S. Wijsenbeek, Rosalba Mele, Francesco Bonella, Maria Molina-Molina, Wim A. Wuyts, Annette Duck
Publikováno v:
European Respiratory Journal, 47(2), 597-606. European Respiratory Society
Patient advocacy groups play an important role in supporting patients with chronic diseases and promoting better care. The aim of this patient–physician initiative was to gather perceptions from European idiopathic pulmonary fibrosis (IPF) patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d8f7d0cd01c2b3e7606a33f1856db53
Real world experiences: Pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis
Publikováno v:
Respiratory Medicine. 108(1):224-226
SummaryIdiopathic pulmonary fibrosis (IPF) is a debilitating condition with life expectancy of two to five years from diagnosis. Treatment strategies for IPF are disappointingly limited and pirfenidone is currently the only licensed drug that has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae159b640c4794c7d9c035c2fbe7cabf
Publikováno v:
1.2 Rehabilitation and Chronic Care.
Background: The idiopathic pulmonary fibrosis (IPF) Care program provides long-term support and education to patients receiving pirfenidone (PFD) in the UK. Through patient-managed discussions with nurses, IPF Care supports patients living with their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa1ad6cdc56009ebb8e0d2a547c30f0e
https://doi.org/10.1183/13993003.congress-2015.pa3695
https://doi.org/10.1183/13993003.congress-2015.pa3695
Autor:
Marlies S. Wijsenbeek, Wim A. Wuyts, Annette Duck, Maria Molina-Molina, Francesco Bonella, Klaus Geissler, Rosalba Mele
Publikováno v:
European Respiratory Journal, 48(1), 283-284. European Respiratory Society
The European IPF Charter paved the way to improve care and raise visibility of the needs of patients affected by ILDhttp://ow.ly/4nrVHV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab0c28c93ef6b0ce803e350dbd13e086
https://doi.org/10.1183/13993003.00604-2016
https://doi.org/10.1183/13993003.00604-2016
Publikováno v:
Journal of Advanced Nursing
Duck, A, Spencer, L G, Bailey, S, Leonard, C, Ormes, J & Caress, A-L 2015, ' Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis ', Journal of Advanced Nursing . https://doi.org/10.1111/jan.12587
Duck, A, Spencer, L G, Bailey, S, Leonard, C, Ormes, J & Caress, A-L 2015, ' Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis ', Journal of Advanced Nursing . https://doi.org/10.1111/jan.12587
Aims To understand the perceptions, needs and experiences of patients with Idiopathic Pulmonary Fibrosis. Background Idiopathic pulmonary fibrosis is a progressive interstitial lung disease, with a mean life expectancy similar to some forms of cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::910ea889fd02eade748913b35a4bed42
https://pubmed.ncbi.nlm.nih.gov/25533573
https://pubmed.ncbi.nlm.nih.gov/25533573
Autor:
Annette, Duck
Publikováno v:
Nursing times. 110(16)
Idiopathic pulmonary fibrosis is a progressive interstitial lung disease; patients have a mean life expectancy of 2-4 years from diagnosis. This review summarises National Institute for Health and Care Excellence (2013a) guidance and identifies key p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8c8c27b5fb003fcf14284c00f8d6e4d6
https://pubmed.ncbi.nlm.nih.gov/24834600
https://pubmed.ncbi.nlm.nih.gov/24834600
Autor:
Lisa Spencer, G NgMan Kwong, Mark S Longshaw, Annette Duck, Jeffrey J. Swigris, Amanda Belkin, Janelle Yorke, Sarah Ratcliffe
Publikováno v:
BMJ Open Respiratory Research
Rationale: The A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF) was developed in the USA to assess health-related quality of life in patients with IPF. It is likely that some of the original ATAQ-IPF items perform differen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c4a87809b6093965f84a4ae6c3021f5
https://usir.salford.ac.uk/id/eprint/35078/1/ATAQ-BMJRespOpen.pdf
https://usir.salford.ac.uk/id/eprint/35078/1/ATAQ-BMJRespOpen.pdf
Publikováno v:
Nursing times. 108(1-2)
Ambulatory oxygen requirements are routinely assessed and titrated using portable finger pulse oximetry. However, movement artefacts from hands moving or reduced circulation may adversely affect the accuracy of measurement. At Wythenshawe Hospital, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::310587cb2781c8c4e5307c3dd795ad22
https://pubmed.ncbi.nlm.nih.gov/22428284
https://pubmed.ncbi.nlm.nih.gov/22428284
Autor:
Annette, Duck
Publikováno v:
Nursing times. 107(15-16)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::600eeebe9a23dcce8ae866444c6983f1
https://pubmed.ncbi.nlm.nih.gov/21661489
https://pubmed.ncbi.nlm.nih.gov/21661489